HCMAW

HCMAW represents warrants of HCM III Acquisition Corp., a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is sponsored by an affiliate of HCM Capital, a private equity firm focused on healthcare and life sciences investments. Each warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustments. HCM III Acquisition Corp. completed its initial public offering in November 2021, raising approximately $345 million. The SPAC targets businesses in the healthcare sector, leveraging HCM Capital's industry expertise and relationships to identify potential combination opportunities. The company's management team brings extensive experience in healthcare investing, operations, and strategic development. As a blank check company, HCM III Acquisition Corp. holds its IPO proceeds in a trust account while searching for a suitable acquisition target. The company operates under a defined timeframe to complete a business combination, typically within 18 to 24 months from its IPO date, with possible extensions. Upon successful completion of a business combination, warrant holders may exercise their warrants to acquire common stock of the resulting entity at the predetermined exercise price.